Viatris VTRS
$ 13.13
0.61%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Robert J. Coury |
Employees in the company |
35 000 |
Shares |
1.21 B |
Market Cap[1] |
$ 15.9 B |
EBITDA (LTM) |
$ 3.15 B |
P/E (LTM) |
42.32 |
P/S (LTM) |
1.03 |
EPS (LTM) |
0.31 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.